Stocks fell slightly as investors took profits in sectors that have been in fashion lately.
The <ENAMEX TYPE="ORGANIZATION">Dow Jones</ENAMEX> Industrial Average fell 3.42 to 2683.89, and <ENAMEX TYPE="ORGANIZATION">Standard & Poor</ENAMEX>'s 500stock index slipped 0.08 to 346.47. Turnover came to 136,640,000 shares on the <ENAMEX TYPE="ORGANIZATION">New York Stock Exchange</ENAMEX>, compared with Tuesday's 141,610,000.
There were further signs in the market that money managers are turning defensive. Traders said they saw a rotation out of sectors that were fashionable only a month ago and a selective flight to blue-chips.
``Of concern to me is the earnings picture,'' said <ENAMEX TYPE="PERSON">William T. Oliver Jr.</ENAMEX>, vice president at <ENAMEX TYPE="ORGANIZATION">Chemical Bank Trust & Investment.</ENAMEX> ``I think earnings in two of the next three quarters will be down. We are sitting on about 15% cash.'' Mr. <ENAMEX TYPE="PERSON">Oliver</ENAMEX> said medium-term bonds -- with terms of about seven years to maturity -- look better than most stocks right now.
Among the recently hot issues that fell out of favor were auto stocks. <ENAMEX TYPE="ORGANIZATION">Ford Motor</ENAMEX> closed down 3/4 at 50 7/8, <ENAMEX TYPE="ORGANIZATION">Chrysler</ENAMEX> fell 3/4 to 25, and <ENAMEX TYPE="ORGANIZATION">General Motors</ENAMEX> slipped 7/8 to 48. On Aug. 15, <ENAMEX TYPE="ORGANIZATION">Oppenheimer</ENAMEX> analyst <ENAMEX TYPE="PERSON">Charles Brady</ENAMEX> told <ENAMEX TYPE="ORGANIZATION">Dow Jones News</ENAMEX> Service the group represents ``excellent value.'' <ENAMEX TYPE="ORGANIZATION">General Motors</ENAMEX> closed at 45 1/2 that day. Yesterday, Mr. <ENAMEX TYPE="PERSON">Brady</ENAMEX> said: ``I am still very positive on the group. What you are seeing is general uncertainty about the {entire} market.''
Drug stocks, another recent investing fad, were sold as well. <ENAMEX TYPE="ORGANIZATION">Abbott Laboratories</ENAMEX> tumbled 1 1/8 to 63, and <ENAMEX TYPE="ORGANIZATION">Pfizer</ENAMEX> eased 1/2 to 67 3/4.
Where are investors running to? Traders said some of the money that hasn't found a home in <ENAMEX TYPE="ORGANIZATION">Treasury</ENAMEX> bills and notes is being invested in utility stocks.
The <ENAMEX TYPE="ORGANIZATION">Dow Jones</ENAMEX> Utility Average outperformed the industrial average for most of the session and closed 0.88 higher at
<ENAMEX TYPE="ORGANIZATION">Commonwealth Edison</ENAMEX> rose 3/8 to 38 1/4, and <ENAMEX TYPE="ORGANIZATION">Detroit Edison</ENAMEX> gained 3/8 to 21 3/4. Both issues were pursued by investors, traders said.
Chase <ENAMEX TYPE="LOCATION">Manhattan</ENAMEX> rose 1 5/8 to 39 1/2. Trading was halted just before the market's close for a news announcement. After the close, Chase stunned traders and analysts by announcing a charge against third-quarter earnings of $1.31 billion, or $1.26 billion after taxes. It cited a fattened reserve for loan losses, some loan write-downs and losses in securities trading.
Dividend-related trading boosted two stocks to the top of the active list, traders said. <ENAMEX TYPE="ORGANIZATION">Southeast Bank</ENAMEX> closed unchanged at 26 1/2 on volume of 1.6 million shares, and <ENAMEX TYPE="ORGANIZATION">Portland General</ENAMEX> gained 1/8 to 23 7/8 on volume of about 1.3 million shares. Both stocks went ex-dividend Tuesday.
<ENAMEX TYPE="ORGANIZATION">Upjohn</ENAMEX> was sixth on the list, losing 1/4 to 36 1/8. The <ENAMEX TYPE="ORGANIZATION">Wall Street Journal</ENAMEX> reported that the <ENAMEX TYPE="ORGANIZATION">Food and Drug Administration</ENAMEX> is investigating the safety of <ENAMEX TYPE="ORGANIZATION">Upjohn</ENAMEX>'s prescription drug Halcion, the most widely prescribed sleeping agent in the world.
Also on the active list, <ENAMEX TYPE="ORGANIZATION">Public Service Enterprise Group</ENAMEX> added 1/8 to 26 1/2. An offering of five million common shares was priced late Tuesday at $26.375 each.
<ENAMEX TYPE="LOCATION">Spain</ENAMEX> Fund soared 7, or 32%, to 28 3/4. Trading in the fund was delayed early in the session because of an order imbalance.
Shares of another closed-end fund that invests in some Spanish securities, <ENAMEX TYPE="ORGANIZATION">First Iberian Fund</ENAMEX>, were also up sharply, gaining 1 3/8 to 12 3/8.
<ENAMEX TYPE="LOCATION">Germany</ENAMEX> Fund gained 1/2 to 11, and a fourth European fund, <ENAMEX TYPE="LOCATION">Italy</ENAMEX> Fund, rose 3/4, or 9.9%, to 10 7/8.
<ENAMEX TYPE="ORGANIZATION">L.A. Gear</ENAMEX>, which fell 4 Tuesday, recovered 2 3/4 to close at 75 3/4. Late Tuesday, <ENAMEX TYPE="PERSON">Robert Greenberg</ENAMEX>, the company's chief executive officer, told an audience of money managers and analysts at a <ENAMEX TYPE="ORGANIZATION">Montgomery Securities</ENAMEX> conference in <ENAMEX TYPE="LOCATION">San Francisco</ENAMEX> that the company's athletic-shoe and sportswear sales in September are expected to break August's record of $120 million in sales.
<ENAMEX TYPE="ORGANIZATION">Storage Technology</ENAMEX> gained 1 3/8 to 12 5/8 after being awarded a $1.7 million contract by the <ENAMEX TYPE="ORGANIZATION">Air Force</ENAMEX> for robotic computer storage equipment.
<ENAMEX TYPE="ORGANIZATION">Ferro</ENAMEX> gained 5/8 to 33 7/8. <ENAMEX TYPE="ORGANIZATION">Merrill Lynch</ENAMEX> raised its rating on the specialty chemicals company to ``neutral'' from ``below average,'' according to <ENAMEX TYPE="ORGANIZATION">Dow Jones</ENAMEX> Professional Investor Report. The brokerage company also boosted its 1990 earnings estimate for <ENAMEX TYPE="ORGANIZATION">Ferro</ENAMEX> to $2.35 a share from $2.13. <ENAMEX TYPE="ORGANIZATION">Merrill</ENAMEX>'s $2.25-a-share 1989 estimate remains unchanged.
<ENAMEX TYPE="ORGANIZATION">Grow Group</ENAMEX> dropped 1/4 to 11 7/8. A shareholder group including <ENAMEX TYPE="LOCATION">Massachusetts</ENAMEX> banker <ENAMEX TYPE="PERSON">Edward S. Buchanan</ENAMEX> said it will try to elect three directors at <ENAMEX TYPE="ORGANIZATION">Grow Group</ENAMEX>'s Oct. 25 annual meeting. If elected, the nominees will pursue the sale of the company, the group said. <ENAMEX TYPE="ORGANIZATION">Grow Group</ENAMEX> said it will ``vigorously oppose'' the group's plan.
The <ENAMEX TYPE="ORGANIZATION">American Stock Exchange</ENAMEX> Index gained 0.31 to 379.14. Volume totaled 12,560,000 shares, compared with 9,990,000 Tuesday. There were 280 issues advancing, 286 declining and 272 unchanged.
ATI Medical rose 1/4 to 9 1/4. A large block of the stock was sold by a <ENAMEX TYPE="LOCATION">Pennsylvania</ENAMEX> thrift that had acquired the stock when a former <ENAMEX TYPE="ORGANIZATION">ATI</ENAMEX> director defaulted on a loan from the thrift. Also on the <ENAMEX TYPE="ORGANIZATION">Amex</ENAMEX>, <ENAMEX TYPE="ORGANIZATION">Turner Broadcasting's</ENAMEX> Class A shares lost 2 3/4 to 47 1/2.
